Neurocrine Bioscience buy Citigroup Inc.
Start price
29.10.25
/
50%
€117.75
Target price
29.10.26
€174.28
Performance (%)
-11.93%
Price
12.02.26
€103.70
Summary
This prediction is currently active. The price of Neurocrine Bioscience has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.93%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -0.856% | -0.856% |
| iShares Core DAX® | 1,30 % | -1,39 % |
| iShares Nasdaq 100 | 0,61 % | -4,17 % |
| iShares Nikkei 225® | 8,77 % | 9,78 % |
| iShares S&P 500 | 0,25 % | -2,30 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
0.34%
12.02.26
12.02.26
